medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2024, Número 2

Siguiente >>

Cir Card Mex 2024; 9 (2)


El ensayo NOTION: algunas preocupaciones sobre el deterioro estructural de la válvula en la bioprótesis quirúrgica. ¿Realidad o ficción?

García-Villarreal OA

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 39-40
Archivo PDF: 179.06 Kb.





REFERENCIAS (EN ESTE ARTÍCULO)

  1. NOTION 10 years - The Nordic aortic valve intervention trial. [Access September 09, 2023] Available in: https://www.pcronline.com/News/Whats-new-on-PCRonline/2023/ESC/NOTION-The-nordic-aortic-valve-intervention-trial

  2. Jorgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021;42(30):2912-2919. doi: 10.1093/eurheartj/ehab375.

  3. Ghoneim A, Bouhout I, Demers P, et al. Management of small aortic annulus in the era of sutureless valves: A comparative study among different biological options. J Thorac Cardiovasc Surg. 2016;152(4):1019-1028. doi: 10.1016/j.jtcvs.2016.06.058.

  4. Update to important information regarding SVD in trifecta family of valves. 2023. Available in: https://www.structuralheart.abbott/fileadmin/pdf/US-Abbott-Trifecta-Customer-Letter-July-2023.pdf

  5. FDA. Abbott trifecta valves: potential risk of early structural valve deterioration - letter to health care providers. 2023. Available in: https://www.fda.gov/medical-devices/letters-health-care-providers/abbott-trifecta-valves-potential-risk-early-structural-valve-deterioration-letter-health-care

  6. Axtell AL, Chang DC, Melnitchouk S, et al. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve. J Card Surg. 2018;33(12):778-786. doi: 10.1111/jocs.13953.

  7. Bassano C, Gislao V, Bovio E, et al. An unexpected risk factor for early structural deterioration of biological aortic valve prostheses. Ann Thorac Surg. 2018;105(2):521-527. doi: 10.1016/j.athoracsur.2017.07.014.

  8. Ruvolo G, Pisano C, Balistreri CR, et al. Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch? J Thorac Dis. 2018;10(4):E270-E274. doi: 10.21037/jtd.2018.03.137.

  9. Mahboubi R, Kakavand M, Soltesz EG, et al. The decreasing risk of reoperative aortic valve replacement: Implications for valve choice and transcatheter therapy. J Thorac Cardiovasc Surg. 2023;166(4):1043-1053.e7. doi: 10.1016/j.jtcvs.2022.02.052.

  10. Yun JJ, Saleh OA, Chung JW, et al. Cardiac operations after transcatheter aortic valve replacement. Ann Thorac Surg. 2022;114(1):52-59. doi: 10.1016/j.athoracsur.2021.10.022.

  11. Jawitz OK, Gulack BC, Grau-Sepulveda MV, et al. Reoperation after transcatheter aortic valve replacement: an analysis of the Society of Thoracic Surgeons Database. JACC Cardiovasc Interv. 2020;13(13):1515-1525. doi: 10.1016/j.jcin.2020.04.029.

  12. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.

  13. Fukuhara S, Kim KM, Yang B, et al. Reoperation following transcatheter aortic valve replacement: Insights from 10 years' experience. J Thorac Cardiovasc Surg. 2023;S0022-5223(23)00353-7. doi: 10.1016/j.jtcvs.2023.04.029.




2020     |     www.medigraphic.com